326 related articles for article (PubMed ID: 35412016)
21. A review of non-alcoholic fatty liver disease in non-obese and lean individuals.
Ahadi M; Molooghi K; Masoudifar N; Namdar AB; Vossoughinia H; Farzanehfar M
J Gastroenterol Hepatol; 2021 Jun; 36(6):1497-1507. PubMed ID: 33217052
[TBL] [Abstract][Full Text] [Related]
22. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
[TBL] [Abstract][Full Text] [Related]
23. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
24. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.
Abenavoli L; Milic N; Peta V; Alfieri F; De Lorenzo A; Bellentani S
World J Gastroenterol; 2014 Dec; 20(45):16831-40. PubMed ID: 25492997
[TBL] [Abstract][Full Text] [Related]
25. (
Molina-Molina E; Shanmugam H; Di Ciaula A; Grattagliano I; Di Palo DM; Palmieri VO; Portincasa P
JHEP Rep; 2021 Feb; 3(1):100203. PubMed ID: 33490935
[TBL] [Abstract][Full Text] [Related]
26. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M
Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526
[TBL] [Abstract][Full Text] [Related]
28. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors.
Al-Dayyat HM; Rayyan YM; Tayyem RF
Diabetes Metab Syndr; 2018 Jul; 12(4):569-575. PubMed ID: 29571977
[TBL] [Abstract][Full Text] [Related]
29. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy].
Petunina NA; Telnova ME; Goncharova EV; Martirosian NS; Kuzina IA
Ter Arkh; 2022 Nov; 94(10):1155-1162. PubMed ID: 36468989
[TBL] [Abstract][Full Text] [Related]
30. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
31. Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.
Baratta F; Pastori D; Polimeni L; Bucci T; Ceci F; Calabrese C; Ernesti I; Pannitteri G; Violi F; Angelico F; Del Ben M
Am J Gastroenterol; 2017 Dec; 112(12):1832-1839. PubMed ID: 29063908
[TBL] [Abstract][Full Text] [Related]
32. Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.
Ayonrinde OT
JHEP Rep; 2021 Jun; 3(3):100261. PubMed ID: 34036255
[TBL] [Abstract][Full Text] [Related]
33. Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!
Katsiki N; Stoian AP; Rizzo M
Clin Investig Arterioscler; 2022 Jun; 34 Suppl 1():S24-S31. PubMed ID: 35131122
[TBL] [Abstract][Full Text] [Related]
34. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
Milić S; Lulić D; Štimac D
World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
[TBL] [Abstract][Full Text] [Related]
35. Non-alcoholic fatty liver disease: a diabetologist's perspective.
Pappachan JM; Antonio FA; Edavalath M; Mukherjee A
Endocrine; 2014 Apr; 45(3):344-53. PubMed ID: 24287794
[TBL] [Abstract][Full Text] [Related]
36. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
[TBL] [Abstract][Full Text] [Related]
37. Non-alcoholic fatty liver disease - how to effectively fight the nowadays most common liver disease?
Šmíd V
Cas Lek Cesk; 2021; 160(2-3):65-70. PubMed ID: 34134495
[TBL] [Abstract][Full Text] [Related]
38. Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner?
Sofi F; Casini A
World J Gastroenterol; 2014 Jun; 20(23):7339-46. PubMed ID: 24966604
[TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors.
Muzurović E; Peng CC; Belanger MJ; Sanoudou D; Mikhailidis DP; Mantzoros CS
Hypertension; 2022 Jul; 79(7):1319-1326. PubMed ID: 35465684
[TBL] [Abstract][Full Text] [Related]
40. Nutritional and Lifestyle Therapy for NAFLD in People with HIV.
Cinque F; Cespiati A; Lombardi R; Guaraldi G; Sebastiani G
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
